Articles
11 June 2009
Vol. 3 No. 1: 2006...2009: Now we know T-cell lymphomas better, Bologna, Italy, 16-18 March 2009
https://doi.org/10.4081/hmr.v3i1.539

Cutaneous T-cell lymphoma, new insights

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
210
Views
177
Downloads

Authors

MB Wozniak
support@pagepress.org
SM Rodriguez Pinilla
R Villuendas
M Herrera
PL Ortiz
MA Piris
Cutaneous T-cell lymphomas (CTCLs) are a heterogeneous group of extranodal non-Hodgkin lymphomas characterized by homing of the tumoral T-cells into the skin.1,2 The most frequent forms of CTCL are mycosis fungoides (MF) and its leukemic counterpart, the Sézary syndrome (SS). Currently, no curative treatment for CTCL is available, and the therapy aims to maintain a long-term complete remission and preserve quality of life. Patients with refractory or transformed MF and with SS have usually poor prognosis and the proposed treatment is mostly palliative.3

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Cutaneous T-cell lymphoma, new insights. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.539